Fundraising Fox

Generation Bio

Cambridge, US · Founded 2016 · Delaware corporation · 4 known investors

Biotech

Founders & leadership

GM
Geoff McDonoughyExecutive
GG
Glenn GoddardExecutive
MA
Mark AngelinoExecutive

Board

JRJason Rhodes
Jason RhodesinBoard directorPartner at Atlas Venture
CSCatherine Stehman-Breen
Catherine Stehman-BreenBoard directorVenture Partner at F-Prime Capital Partners
AQ
Anthony QuinnBoard director
GC
Gustav ChristensenBoard director
DN
Donald NicholsonBoard director

Investors · 4

Atlas VentureCambridge · $500K – $1M
Foresite CapitalWest Hollywood
F-Prime CapitalreportedCambridge · $3M – $10Mvia Catherine Stehman-Breen · board
InvusreportedNew York

Reported raises · per SEC filings

Form D private placements

$211.8M disclosed across 2 rounds · 2018–2020

▶$111.5MraisedJan 2020 · 54 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Anthony QuinnDirector
  • Geoffrey McDonoughExecutive Officer, Director
  • Jason RhodesDirector
  • Jeff JonasDirector
  • Charlie RowlandDirector
  • Catherine Stehman-BreenDirector
  • Thomas GraneyExecutive Officer
  • Donald NicholsonDirector
  • Gustav ChristensenDirector
  • Mark AngelinoExecutive Officer
Offering amount
$111.5M
Amount sold
$111.5M
First sale
Jan 2020
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$100.4MraisedMar 2018 · 26 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Geoff McDonoughyExecutive Officer, Director
  • Glenn GoddardExecutive Officer
  • Jason RhodesDirector
  • Anthony QuinnDirector
  • Gustav ChristensenDirector
  • Donald NicholsonDirector
  • Catherine Stehman-BreenDirector
  • Mark AngelinoExecutive Officer
Offering amount
$100.4M
Amount sold
$100.4M
First sale
Feb 2018
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

3 people who came through Generation Bio went on to found or lead other companies.

Jason RhodesDirectorFounded Rectifypharma +1Phillip SamayoaSenior Vice President, Head of Corporate DevelopmentFounded Dyne Therapeutics +1Jeffrey M. JonasDirectorFounded Sage Therapeutics

In the news

Generation Bio Co stock (US37148B1061): Eli Lilly deal fuels fresh attention on DNA-delivery specialad-hoc-news.de · May 2026BioCentury - Generation Bio raises $100M series Bbiocentury.com · Feb 2018Generation Bio Raises $100 Million Series B to Finance Non-Viral Gene Therapy Program - BioSpacebiospace.com · Feb 2018Hauling in a $100M mega-round, gene therapy startup Generation Bio builds alternative to potentially risky viral vectorsendpoints.news · Feb 2018Generation Bio raises $100M for ‘druglike’ gene therapy | Fierce Biotechfiercebiotech.com · Feb 2018

Frequently asked questions

Who are Generation Bio's investors?
Generation Bio's investors include Atlas Venture, Foresite Capital, F-Prime Capital, Invus.
How much funding has Generation Bio raised?
Generation Bio has disclosed $211.8M raised across 2 rounds.
Where is Generation Bio headquartered?
Generation Bio is headquartered in Cambridge, US.